Canada· CA-DIN-02244148
PROTOPIC
A tacrolimus product containing tacrolimus, registered in Canada by LEO PHARMA INC. The same ATC class is registered in 12 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Tacrolimus is registered in 12 of 19 countries.
Countries holding a registration under ATC D11AH01 (tacrolimus), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 8 of them publish a price we can compare per daily dose
Tacrolimus · ATC D11AH01
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- TACROLIMUS
- Manufacturer
- LEO PHARMA INC
- Country
- Canada (CA)
- ATC code
- D11AH01
- ATC class
- Tacrolimus
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tacrolimus in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandDermitopicBausch Health Ireland Ltd.
- FinlandProtopicLeo Pharma A/S
- CzechiaPROTOPICLEO Pharma A/S, Ballerup
- IcelandProtopicLEO Pharma A/S*
- United StatesASTAGRAF XLAstellas Pharma US, Inc.
- SwedenAdoport 0,5 mg Kapsel, hårdOrifarm AB
- United KingdomAdoport 0.5mg capsulesSandoz Ltd
- NetherlandsAdport 0,5 mg, capsules, hardEuro Registratie Collectief B.V.
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Adport, Dailiport
- Belgium · Adoport, Dailiport
- Bulgaria · Програф
- Cyprus · Prograf, Tacrolimus Accord
- Czechia · Dailiport, Gecrol
- Germany · Crilomus, Dailiport
- Denmark · Adport, Dailiport
- Estonia · Dailiport, Lebsanan
- Spain · Adoport, Cellmune
- Finland · Adport, Adport,
- France · Adoport, Conferoport
- United Kingdom (Northern Ireland) · Adoport, Ascezo
- Greece · Atodrit-Dermo, Eczatope Derm
- Croatia · Atezyrix, Dermitopic
- Hungary · Prograf, Tacrolimus Stada
- Ireland · Prograf, Tacrolimus Accord
- Iceland · Advagraf, Dailiport
- Italy · Adoport, Carelimus
- Liechtenstein · Advagraf, Envarsus
- Lithuania · Dailiport, Lebsanan
- Luxembourg · Prograft, Sumilor
- Latvia · Dailiport, Lebsanan
- Malta · Prograf
- Netherlands · Adport, Conferoport
- Norway · Adport, Advagraf
- Poland · Cidimus, Dailiport
- Portugal · Adoport, Dermitopic
- Romania · Prograf, Tacrolimus Sandoz
- Sweden · Adport, Adport,
- Slovenia · Adoport, Dailiport
- Slovakia · Atezyrix, Dailiport
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/78db59f3-1900-426f-a44e-4ed6ddca58a2 GET /v1/drugs/78db59f3-1900-426f-a44e-4ed6ddca58a2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02244148",
"form": "OINTMENT",
"class": "Human",
"routes": [
"TOPICAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "D11AH01",
"schedule": [
"Prescription"
],
"drug_code": "68109",
"strengths": [
"0.1 %"
],
"ahfs_class": null,
"substances": [
"TACROLIMUS"
],
"product_categorization": null
}See everything about tacrolimus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.